CE认证
皮肤填充剂
Neauvia Intense Rose is a sterile, non-pyrogenic, injectable monophasic filler, indicated for the correction of vulvar atrophy and its related symptoms. It is administered by intradermal injection, and the product degrades slowly after implanting. The gelatinous, transparent and colourless hydrogel consists of highly purified sodium hyaluronate of non-animal origin, derived from bacterial fermentation and cross-linked with PEG at 28 mg/mL, with glycine and L-proline in buffered non-pyrogenic water, and it contains no anaesthetic. It is supplied in a pre-filled 1.0 ml disposable syringe with a luer-lock connection.
主要优势： Neauvia Intense Rose
- Indicated for the correction of vulvar atrophy and the symptoms related to it
- 28 mg/mL cross-linked sodium hyaluronate of non-animal origin from bacterial fermentation
- Enriched with glycine and L-proline in buffered non-pyrogenic water
- Contains no anaesthetic, which reduces the scope for allergic reaction
- Supplied in a pre-filled 1.0 ml disposable syringe with a luer-lock connection
- Suitable for use with a needle from 21G up to 25G
- Degrades slowly after implanting
适应症与专业用途
主要适应症
- Correction of vulvar atrophy
- Correction of the symptoms related to vulvar atrophy
专业用途
For professional use. Use of Neauvia Intense Rose is reserved exclusively for trained practitioners with a good anatomical knowledge of the site to be treated, and it is not for retail sale or self-administration. It must be implanted in proper conditions in a suitable environment, with the current rules of asepsis rigorously observed and the skin disinfected with iodopovidone or chlorhexidine. It must not be injected into blood vessels, into the clitoral area or labia minora, into areas too close to or within the urethra, or into the mammary gland or internal genitals, and it must not be injected close to menstruation, used simultaneously with laser treatment, deep chemical peels or dermabrasion, or overcorrected.
治疗部位
- Labia majora
适用患者
For adult patients presenting with vulvar atrophy, assessed by a practitioner with good anatomical knowledge of the site to be treated. It must not be used in patients with auto-immune disorders affecting the skin; infections or inflammations such as genital herpes or dermatitis at or near the treatment zone; varices in the area of the implant; patients receiving anticoagulant treatment; patients undergoing radiation or ultrasound therapy in the area of the implant; known hypersensitivity to hyaluronic acid; a tendency to develop hypertrophic scarring; untreated epilepsy; or severe allergies. It must not be injected in pregnant or breastfeeding women, in anyone under 18 years of age, or in patients already treated with temporary or permanent fillers in the same area.
作用原理： Neauvia Intense Rose
Intense Rose is injected intradermally into the labia majora, where the cross-linked hydrogel restores volume lost to vulvar atrophy. The recommended technique is slow, retrograde sliding injection, with the product shaped by the operator's free hand during placement and the treated area massaged gently afterwards to distribute it. Because the device contains no anaesthetic, the practitioner assesses separately whether local anaesthesia is appropriate; where it is, a troncular nerve block is advised. The gel degrades slowly after implanting rather than resolving to a fixed endpoint.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 NEAUVIA 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
How does Neauvia Intense Rose differ from the rest of the Neauvia range?
Indication and regulatory route. Neauvia Intense Rose is the only reference indicated for vulvar atrophy, placed intradermally in the labia majora, and it is regulated as a Class III device under the Medical Device Directive 93/42/EEC with notified body 0373. The face and lip references are regulated under Regulation (EU) 2017/745.
What should the patient avoid after treatment with Neauvia Intense Rose?
Sexual activity for five days, activities that put pressure on the treated area such as cycling or horseback riding for several days, wet locations including swimming pools, gyms and steam rooms for ten days, intense UVA-B and sun exposure for two weeks, surgery or dental work for two weeks, and beauty treatments such as laser or peeling in the treated area for three weeks.
更多产品： Matex Lab S.P.A
美塑疗法
诊所替代选择
/ 最近浏览
继续浏览
Neauvia Intense Rose is a sterile, non-pyrogenic, injectable monophasic filler, indicated for the correction of vulvar atrophy and its related symptoms. It is administered by intradermal injection, and the product degrades slowly after implanting. The gelatinous, transparent and colourless hydrogel consists of highly purified sodium hyaluronate of non-animal origin, derived from bacterial fermentation and cross-linked with PEG at 28 mg/mL, with glycine and L-proline in buffered non-pyrogenic water, and it contains no anaesthetic. It is supplied in a pre-filled 1.0 ml disposable syringe with a luer-lock connection.
主要优势： Neauvia Intense Rose
- Indicated for the correction of vulvar atrophy and the symptoms related to it
- 28 mg/mL cross-linked sodium hyaluronate of non-animal origin from bacterial fermentation
- Enriched with glycine and L-proline in buffered non-pyrogenic water
- Contains no anaesthetic, which reduces the scope for allergic reaction
- Supplied in a pre-filled 1.0 ml disposable syringe with a luer-lock connection
- Suitable for use with a needle from 21G up to 25G
- Degrades slowly after implanting
适应症与专业用途
主要适应症
- Correction of vulvar atrophy
- Correction of the symptoms related to vulvar atrophy
专业用途
For professional use. Use of Neauvia Intense Rose is reserved exclusively for trained practitioners with a good anatomical knowledge of the site to be treated, and it is not for retail sale or self-administration. It must be implanted in proper conditions in a suitable environment, with the current rules of asepsis rigorously observed and the skin disinfected with iodopovidone or chlorhexidine. It must not be injected into blood vessels, into the clitoral area or labia minora, into areas too close to or within the urethra, or into the mammary gland or internal genitals, and it must not be injected close to menstruation, used simultaneously with laser treatment, deep chemical peels or dermabrasion, or overcorrected.
治疗部位
- Labia majora
适用患者
For adult patients presenting with vulvar atrophy, assessed by a practitioner with good anatomical knowledge of the site to be treated. It must not be used in patients with auto-immune disorders affecting the skin; infections or inflammations such as genital herpes or dermatitis at or near the treatment zone; varices in the area of the implant; patients receiving anticoagulant treatment; patients undergoing radiation or ultrasound therapy in the area of the implant; known hypersensitivity to hyaluronic acid; a tendency to develop hypertrophic scarring; untreated epilepsy; or severe allergies. It must not be injected in pregnant or breastfeeding women, in anyone under 18 years of age, or in patients already treated with temporary or permanent fillers in the same area.
作用原理： Neauvia Intense Rose
Intense Rose is injected intradermally into the labia majora, where the cross-linked hydrogel restores volume lost to vulvar atrophy. The recommended technique is slow, retrograde sliding injection, with the product shaped by the operator's free hand during placement and the treated area massaged gently afterwards to distribute it. Because the device contains no anaesthetic, the practitioner assesses separately whether local anaesthesia is appropriate; where it is, a troncular nerve block is advised. The gel degrades slowly after implanting rather than resolving to a fixed endpoint.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 NEAUVIA 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
How does Neauvia Intense Rose differ from the rest of the Neauvia range?
Indication and regulatory route. Neauvia Intense Rose is the only reference indicated for vulvar atrophy, placed intradermally in the labia majora, and it is regulated as a Class III device under the Medical Device Directive 93/42/EEC with notified body 0373. The face and lip references are regulated under Regulation (EU) 2017/745.
What should the patient avoid after treatment with Neauvia Intense Rose?
Sexual activity for five days, activities that put pressure on the treated area such as cycling or horseback riding for several days, wet locations including swimming pools, gyms and steam rooms for ten days, intense UVA-B and sun exposure for two weeks, surgery or dental work for two weeks, and beauty treatments such as laser or peeling in the treated area for three weeks.
更多产品： Matex Lab S.P.A
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。